Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GPC3-targeted CAR-T in Advanced HCC
NCT06641453Phase 2Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Nov 2024
- Primary completion
- Nov 2027
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of GPC3-CART cells in hepatocellular carcinoma (HCC), sponsored by Chinese PLA General Hospital. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
GPC3-CART cells
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT06641453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06641453.